Adenosine inhibits lipopolysaccharide-induced secretion of tumor necrosis factor-α in the failing human heart

Circulation

Volumn 97, Issue 6, 1998, Pages 521-524

  Wagner, Daniel R ^b   McTiernan, Charles ^b   Sanders, Virginia J ^a   Feldman, Arthur M ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b Scaife Hall S572 ^*

Author keywords

Adenosine; Heart failure; Proteins; Tumor necrosis factor

Indexed keywords

6 N [2 (3,5 DIMETHOXYPHENYL) 2 (2 METHYLPHENYL)ETHYL]ADENOSINE; ADENOSINE; ADENOSINE KINASE INHIBITOR; ADENOSINE RECEPTOR BLOCKING AGENT; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CYTOKINE RELEASE; DRUG EFFECT; HEART FAILURE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL;

EID: 0031913938     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.6.521     Document Type: Article

References (13)

1. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990;323:236-241.
2. Eichenholz P, Eichacker PQ, Hoffman WD, Banks SM, Parrilo JE, Danner RT, Natanson C. Tumor necrosis factor challenges in canines: patterns of cardiovascular dysfunction. Am J Physiol. 1992;263:H668-H675.
3. Torre-Amione G, Kapadia S, Lee J. Durand JB, Bies RD, Young JB, Mann DL. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation. 1996;93:704-711.
4. Kapadia SR, Oral H, Lee J, Nakano M, Taffet GE, Mann DL. Hemodynamic regulation of tumor necrosis factor-α gene and protein expression in adult feline myocardium. Circ Res. 1997;81:187-195.
5. Kubota T, McTiernan CF, Frye CS, Slawson SE, Koretsky AP, Demetris AJ, Feldman AM. Dilated cardiomyopathy in transgenic mice with cardiacspecific overexpression of tumor necrosis factor-alpha. Circ Res. 1997;81: 627-635.
6. Matsui S, Matsumori A, Matoba Y, Uchida A, Sasayama S. Treatment of virus-induced myocardial injury with a novel immunomodulating agent, vesnarinone: suppression of natural killer cell activity and tumor necrosis factor-α production. J Clin Invest. 1994;94:1212-1217.
7. Matsumori A, Shioi T, Yamada T, Matsui S, Sasayama S. Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure. Circulation. 1994;89:955-958.
8. Matsumori A, Ono K, Nishio R, Nose Y, Sasayama S. Amiodarone inhibits production of tumor necrosis factor-α by human mononuclear cells: a possible mechanism for its effect in heart failure. Circulation. 1997; 96:1386-1389.
9. Matsumori A, Ono K, Nishio R, Igata H, Shioi T, Matsui S, Furukawa Y, Iwasaki A, Nose Y, Sasayama S. Modulation of cytokine production and protection against lethal endotoxemia by the cardiac glycoside ouabain. Circulation. 1997;96:1501-1506.
10. Parmely MJ, Zhou WW, Edwards CK III, Borcherding DK, Silverstein R, Morrison DC. Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-α production and protect mice against endotoxin challenge. J Immmiol. 1993;151:389-396.
11. Wagner DR, Combes A, McTiernan C, Sanders VJ, Lemster B, Feldman AM. Adenosine inhibits lipopolysaccharide-induced cardiac expression of tumor necrosis factor-α. Circ Res. 1998;82:47-56.
12. Matsumori A, Ono K, Sato Y, Shioi T, Nose Y, Sasayama S. Differential modulation of cytokine production by drugs: implications for therapy in heart failure. J Mol Cell Cardiol. 1996;28:2491-2499.
13. Herskowitz A, Choi S, Anasari AA, Wesselingh S. Cytokine mRNA expression in postischemic/reperfused myocardium. Am J Pathol. 1995;146: 419-428.